These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19506537)

  • 1. Impact of international guidelines on the management of cardiovascular risk factors in diabetic patients with peripheral arterial disease.
    Margeta C; Giurgea A; Hammer A; Schlager O; Zehetmayer S; Koppensteiner R; Willfort-Ehringer A
    Int Angiol; 2009 Jun; 28(3):175-80. PubMed ID: 19506537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
    Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
    Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.
    Jaussi A; Noll G; Meier B; Darioli R
    Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):363-72. PubMed ID: 20168234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the gap between National Cholesterol Education Program guidelines and clinical practice in secondary care: results of a cross-sectional study involving over 10 000 patients followed in different specialty settings across Italy.
    Rapezzi C; Biagini E; Bellis P; Cafiero M; Velussi M; Ceriello A; Cooke RM; Schweiger C;
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):878-87. PubMed ID: 18695423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
    Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
    Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid therapy in daily routine].
    Sonntag F; Schaefer JR; Gitt AK; Weizel A; Jannowitz C; Karmann B; Pittrow D; Bestehorn K
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2047-52. PubMed ID: 23023622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid goal achievement and trends in lipid-lowering therapy in veterans undergoing carotid endarterectomy.
    Fitzgerald TN; Popp C; Dardik A; Federman DG
    Vasc Med; 2009 Feb; 14(1):21-7. PubMed ID: 19144776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic syndrome in dyslipidemia consultations.
    Monteiro S; Dias P; Madeira S; de Moura P; Silva JM; Providência LA; Alves de Moura JJ
    Rev Port Cardiol; 2006 Sep; 25(9):821-31. PubMed ID: 17100172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dyslipidaemia in patients treated with lipid-modifying drugs in the Netherlands. Part of the dyslipidaemia international survey.
    Strang AC; Kaasjager HA; Basart DC; Stroes ES
    Neth J Med; 2010 Apr; 68(4):168-74. PubMed ID: 20421658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of guidelines of the management of cardiovascular risk factors in diabetic patients with macrovascular disease.
    Kollias A; Xilomenos A; Ikonomopoulou K; Tolis A
    Int Angiol; 2010 Feb; 29(1):87-8. PubMed ID: 20224540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.